Impacting OS in Patients with Unresectable HCC with 1L TIS
Tislelizumab (TIS) is a specific monoclonal antibody targeting programmed cell death protein 1...
Read More
Dissemination (Meeting Coverage)
Adjuvant Atezolizumab Impact on Recurrence Prevention and Cost Reduction in Early PD-L1 High NSCLC
Recurrent cases of non-small cell lung cancer (NSCLC) following surgery are common and carry...
Read More
Race and Curative-Intent Treatment Linked To Mortality Outcomes in Early-Stage NSCLC
In recent decades, persistent disparities in the survival of individuals with early-stage...
Read More
New Blood-Based RNA Platform for Early Lung Cancer Diagnosis
Blood-based methods utilizing circulating tumor DNA (ctDNA) and cell-free DNA (cfDNA) are...
Read More
CtDNA as Outcome Predictor in NSCLC Undergoing Targeted Therapies: A Meta-Analysis
For treating non-small cell lung cancer (NSCLC), liquid biopsy (LB) was analyzed using...
Read More
Adjuvant Chemotherapy in High-Risk, Early-Stage NSCLC with Clinical and Pathologic Features Reevaluated
Surgical resection is the preferred treatment for early-stage non-small cell lung cancer (NSCLC),...
Read More
FOF and Concern of Falling in Patients with Relapsing-Remitting or Progressive MS
Frequent falls and the fear of falling (FOF) are significant challenges experienced by individuals...
Read More
Mindfulness-Based Stress Reduction in MS: Correlates of Patient-Reported Outcomes and MRI Findings
Researchers conducted a study to examine the effects of mindfulness-based stress reduction (MBSR)...
Read More
Low-Fat Diet Trial: Assessing Fatigue in Multiple Sclerosis
Fatigue is a common and debilitating symptom among individuals with multiple sclerosis (MS)....
Read More
Pharmacological Comparison of Tolebrutinib with Other BTK Inhibitor Candidates for MS Treatment
Tolebrutinib, a covalent inhibitor of Bruton tyrosine kinase (BTK), has been specifically...
Read More
MRI Results of Tolebrutinib Long-Term Safety Extension Study in Relapsing MS
Tolebrutinib, a potent inhibitor of Bruton tyrosine kinase that can cross the blood-brain barrier,...
Read More
MS Therapies Not Associated With Pregnancy Complications
A registry data analysis concluded that most disease-modifying therapies for MS are not associated...
Read More
Q&A: Can Remyelination of Axons Restore Vision in MS?
The VISIONARY-MS trial showed that CNM-Au8, an oral liquid suspension of gold nanoparticles,...
Read More
Orphan Non-Coding RNAs Have Potential for Early Identification of NSCLC
Orphan non-coding RNAs demonstrated efficacy for accurate, sensitive, and early detection of...
Read More
SphK2 Shows Promise for Overcoming NSCLC Tumor Progression
Sphingosine kinase 2 may be a promising clinical target for overcoming EGFR-TKI resistance and...
Read More
Stem Cell Therapy Improves Walking in More Advanced Progressive MS
Intrathecal mesenchymal stem cell-neural progenitor therapy failed to significantly improve the...
Read More
Gold Nanocrystals May Be Effective as Adjunctive MS Therapy
The VISIONARY-MS study suggests catalytically active gold nanocrystals given in addition to...
Read More
Teriflunomide Prevents Conversion to MS in Patients With RIS
In people with radiologically isolated syndrome, teriflunomide resulted in a 62% risk decline for...
Read More
Adherence to Imaging Guidelines ‘Very Poor’ After Early NSCLC Treatment
Among patients with early non-small cell lung cancer, researchers observed low adherence to...
Read More
Higher Stroke Risk in Women With HIV Driven By Age & Comorbidities
Compared with men with HIV, women with HIV who had a stroke were younger, more likely to be...
Read More